Clinical trials
Phase 3 Heart Failure trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
| Completed | 9 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 7 |
| AstraZeneca | 4 |
| Bayer | 3 |
| Boehringer Ingelheim | 2 |
| Novo Nordisk A/S | 2 |
| Amgen | 1 |
| Boston Scientific Corporation | 1 |
| CSL Behring | 1 |
| Chun-Yao Huang | 1 |
| Colorado Prevention Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 26 |
| Cardiovascular Diseases | 3 |
| Aortic Valve Stenosis | 2 |
| Atrial Fibrillation | 2 |
| Dyslipidemias | 2 |
| Hypercholesterolemia | 2 |
| Hyperlipidemias | 2 |
| Hyperlipoproteinemia Type II | 2 |
| Obesity | 2 |
| Ventricular Dysfunction, Left | 2 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.